← Browse by Condition
Medical Condition
stomach cancer
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 2
NCT05494060 Phase 2
Recruiting
XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma
Enrollment
80 pts
Location
China
Sponsor
The First Affiliated Hospital ...
NCT06263088
Recruiting
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
Enrollment
200 pts
Location
United States
Sponsor
Case Comprehensive Cancer Cent...
NCT05426135
Recruiting
Artificial Intelligence System for Assessment of Tumor Risk and Diagnosis and Treatment
Enrollment
3,000 pts
Location
China
Sponsor
Union Hospital, Tongji Medical...
NCT04907643
Recruiting
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Enrollment
360 pts
Location
United States
Sponsor
Cedars-Sinai Medical Center